RKLB Stock Price Forecast: How Much Upside Do Analysts See Post-Q3 Earnings?
Rocket Lab USA (RKLB) reported a Q3 EPS loss of $0.12, missing estimates, but revenue rose 73% YoY to $268M, beating forecasts. The company's backlog reached $3.57B, up 52% QoQ. Analysts maintain a Strong Buy rating with an average price target of $95.35, suggesting 52% upside. RKLB shares are down 10% YTD.
How this was made
The 30-second read
Why it matters
The earnings miss may trigger short‑term sell pressure, but revenue beat and backlog record could attract value investors.
Market read
First‑report earnings data for a mid‑cap aerospace firm, with mixed catalyst impact on the stock.
What to watch
Potential supply‑chain constraints for Neutron rockets and upcoming launch schedule could affect future results.
Background
Rocket Lab's Q3 earnings were released, providing fresh financial metrics and analyst commentary.
Ticker impact
Rocket Lab reported Q3 EPS loss of $0.12 versus $0.07 estimate, revenue up 73% to $268M beating forecasts, and a record $3.57B backlog.
likely modest pressure as the loss miss is priced in, though revenue beat could cushion the decline.
Loss miss is a negative catalyst, but the sizable revenue beat and backlog growth provide upside support.
Market effects
Highlights strength in the small‑sat launch market, may boost peers in the space sector.
U.S. aerospace sector sees modest uplift from Rocket Lab's revenue beat.
Backlog growth signals continued demand for launch services worldwide.
Counterpoint
Despite the loss, the expanding backlog could justify a buy on long‑term growth potential.
Key entities
- companyRocket Lab USA
U.S. aerospace launch provider.
- analyst_firmKeyBanc
Provided a Buy rating and $100 price target.
- analyst_firmBarclays
Reduced price target to $82 while maintaining Buy rating.
